tailieunhanh - Biologic predictors of clinical improvement in rituximab-treated refractory myositis

To examine the longitudinal utility of a biomarker signature in conjunction with myositis autoantibodies (autoAbs) as predictors of disease improvement in refractory myositis patients treated with rituximab. |

TỪ KHÓA LIÊN QUAN